The DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
Expert Panel Recommendations for the Use of Anti–Tumor Necrosis Factor Biologic Agents in Patients with Ocular Inflammatory Disorders
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
GRADE guidelines: 3. Rating the quality of evidence
Balshem, H., Helfand, M., Schünemann, H. J., Oxman, A. D., Kunz, R., Brozek, J., Vist, G. E., Falck-Ytter, Y., Meerpohl, J., & Norris, S. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.07.015 · Cited by 8,285
Criteria for diagnosis of Behçet's disease
Weichsler, B., Davatchi, F., Lehner, T., O’Duffy, J. D., Rigby, A. S., & Gregory, J. K. (1990) · The Lancet · Cited by 3,082
Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
Stone, J. H., Merkel, P. A., Spiera, R., Seo, P., Langford, C. A., Hoffman, G. S., Kallenberg, C. G. M., St. Clair, E. W., Turkiewicz, A., Tchao, N. K., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909905 · Cited by 2,762
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.supplement_3.ats600 · Cited by 1,241
Saag, K. G., Teng, G. G., Patkar, N. M., Anuntiyo, J., Finney, C., Curtis, J. R., Paulus, H. E., Mudano, A., Pisu, M., Elkins‐Melton, M., et al. (2008) · Arthritis Care & Research · doi:10.1002/art.23721 · Cited by 1,157
[Criteria of diagnosis of Behcet's disease].
Hamza, M., Zribi, A., & Ben Ayed, H. (1976) · PubMed · Cited by 1,148
Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)
van Dullemen, H. M., van Deventer, S. J. H., Hommes, D. W., Bijl, H. A., Jansen, J., Tytgat, G. N. J., & Woody, J. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90277-5 · Cited by 1,084
Jabs, D. A., Rosenbaum, J. T., Foster, C. S., Holland, G. N., Jaffe, G. J., Louie, J. S., Nussenblatt, R. B., Stiehm, E. R., Tessler, H., Van Gelder, R. N., et al. (2000) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(00)00659-0 · Cited by 995
Self-citationTH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1
Amadi-Obi, A., Yu, C.-R., Liu, X., Mahdi, R. M., Clarke, G. L., Nussenblatt, R. B., Gery, I., Lee, Y. S., & Egwuagu, C. E. (2007) · Nature Medicine · doi:10.1038/nm1585 · Cited by 865
Etanercept plus Standard Therapy for Wegener's Granulomatosis
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa041884 · Cited by 834
Mohler, K. M., Torrance, D. S., Smith, C. A., Goodwin, R. G., Stremler, K. E., Fung, V. P., Madani, H., & Widmer, M. B. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.3.1548 · Cited by 832
Scallon, B. (1995) · Cytokine · doi:10.1006/cyto.1995.0029 · Cited by 675
Wolfe, F., & Michaud, K. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20311 · Cited by 644
Tubach, F., Salmon, D., Ravaud, P., Allanore, Y., Goupille, P., Bréban, M., Pallot‐Prades, B., Pouplin, S., Sacchi, A., Chichemanian, R. M., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24632 · Cited by 632
Baecklund, E., Ekbom, A., Sparén, P., Feltelius, N., & Klareskog, L. (1998) · BMJ · doi:10.1136/bmj.317.7152.180 · Cited by 394
Assessing the quality of research.
Glasziou, P., Vandenbroucke, J., & Chalmers, I. (2004) · BMJ · doi:10.1136/bmj.328.7430.39 · Cited by 391
Ocular Involvement in Chronic Sarcoidosis
Jabs, D. A., & Johns, C. J. (1986) · American Journal of Ophthalmology · doi:10.1016/0002-9394(86)90001-2 · Cited by 391
Self-citationRheumatoid arthritis and cancer risk
Mellemkjær, L., Linet, M. S., Gridley, G., Frisch, M., Møller, H., & Olsen, J. H. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(96)00210-9 · Cited by 383
Wolfe, F., & Michaud, K. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22579 · Cited by 348
Ohno, S., Nakamura, S., Hori, S., Shimakawa, M., Kawashima, H., Mochizuki, M., Sugita, S., Ueno, S., Yoshizaki, K., & 稲葉, 午. (2004) · PubMed · Cited by 343
Do tumor necrosis factor inhibitors cause uveitis? A registry‐based study
Lim, L. L., Fraunfelder, F. W., & Rosenbaum, J. T. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22918 · Cited by 315
Self-citationTreatment of Sarcoidosis With Infliximab
Doty, J. D., Mazur, J. E., & Judson, M. A. (2005) · Chest · doi:10.1378/chest.127.3.1064 · Cited by 312
Smith, J. A., Thompson, D. J. S., Whitcup, S. M., Suhler, E., Clarke, G., Smith, S., Robinson, M., Kim, J., & Barron, K. S. (2005) · Arthritis Care & Research · doi:10.1002/art.20904 · Cited by 308
Suhler, E. B. (2005) · Archives of Ophthalmology · doi:10.1001/archopht.123.7.903 · Cited by 306
Psoriasis induced by anti–tumor necrosis factor therapy: A paradoxical adverse reaction
Sfikakis, P. P., Iliopoulos, A., Elezoglou, A., Kittas, C., & Stratigos, A. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21233 · Cited by 301
Anti-TNF therapy in the management of Behcet's disease--review and basis for recommendations
Sfikakis, P. P., Markomichelakis, N., Alpsoy, E., Assaad-Khalil, S., Bodaghi, B., Gul, A., Ohno, S., Pipitone, N., Schirmer, M., Stanford, M., et al. (2007) · Rheumatology · doi:10.1093/rheumatology/kem034 · Cited by 301
Etanercept therapy in children with treatment-resistant uveitis
Reiff, A., Takei, S., Sadeghi, S., Stout, A., Shaham, B., Bernstein, B., Gallagher, K., & Stout, T. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200106)44:6<1411::aid-art235>3.0.co;2-o · Cited by 298
Rudwaleit, M., Rødevand, E., Holck, P., Vanhoof, J., Kron, M., Kary, S., & Kupper, H. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.092585 · Cited by 297
Lopez-Olivo, M. A., Tayar, J. H., Martinez-Lopez, J. A., Pollono, E. N., Cueto, J. P., Gonzales-Crespo, M. R., Fulton, S., & Suarez-Almazor, M. E. (2012) · JAMA · doi:10.1001/2012.jama.10857 · Cited by 295
Adalimumab in the therapy of uveitis in childhood
Biester, S., Deuter, C., Michels, H., Haefner, R., Kuemmerle-Deschner, J., Doycheva, D., & Zierhut, M. (2007) · British Journal of Ophthalmology · doi:10.1136/bjo.2006.103721 · Cited by 294
Wooley, P. H., Dutcher, J., Widmer, M. B., & Gillis, S. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.11.6602 · Cited by 293
Diak, P., Siegel, J., La Grenade, L., Choi, L., Lemery, S., & McMahon, A. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27511 · Cited by 253
Thorne, J. E., Woreta, F., Kedhar, S. R., Dunn, J. P., & Jabs, D. A. (2007) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.01.033 · Cited by 242
Self-citationTreatment of Refractory Uveitis with Adalimumab: A Prospective Multicenter Study of 131 Patients
Díaz-Llopis, M., Salom, D., Garcia-de-Vicuña, C., Cordero-Coma, M., Ortega, G., Ortego, N., Suarez-de-Figueroa, M., Rio-Pardo, M. J., Fernandez-Cid, C., Fonollosa, A., et al. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.02.018 · Cited by 233
Pathogenesis of ankylosing spondylitis
Tam, L.-S., Gu, J., & Yu, D. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.79 · Cited by 232
Tumour necrosis factor α inhibitors in the treatment of childhood uveitis
Saurenmann, R. K., Levin, A. V., Rose, J. B., Parker, S., Rabinovitch, T., Tyrrell, P. N., Feldman, B. M., Laxer, R. M., Schneider, R., & Silverman, E. D. (2006) · Rheumatology · doi:10.1093/rheumatology/kel030 · Cited by 216
Jones, L. S., Rizzo, L. V., Agarwal, R. K., Tarrant, T. K., Chan, C. C., Wiggert, B., & Caspi, R. R. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.12.5997 · Cited by 214
Efficacy of Etanercept in Preventing Relapse of Uveitis Controlled by Methotrexate
Foster, C. S. (2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.4.437 · Cited by 213
Favorable Response to High-Dose Infliximab for Refractory Childhood Uveitis
Kahn, P., Weiss, M., Imundo, L. F., & Levy, D. M. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.01.005 · Cited by 210
Differential Effectiveness of Etanercept and Infliximab in the Treatment of Ocular Inflammation
Galor, A., Perez, V. L., Hammel, J. P., & Lowder, C. Y. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.04.038 · Cited by 210
Tynjälä, P., Lindahl, P., Honkanen, V., Lahdenne, P., & Kotaniemi, K. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.058248 · Cited by 206
Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry
Mariette, X., Tubach, F., Bagheri, H., Bardet, M., Berthelot, J. M., Gaudin, P., Heresbach, D., Martin, A., Schaeverbeke, T., Salmon, D., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.117762 · Cited by 206
The relationship between infliximab treatment and lymphoma in Crohn's disease
Bickston, S. J., Lichtenstein, G. R., Arseneau, K. O., Cohen, R. B., & Cominelli, F. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70294-5 · Cited by 203
Simonini, G., Taddio, A., Cattalini, M., Caputo, R., De Libero, C., Naviglio, S., Bresci, C., Lorusso, M., Lepore, L., & Cimaz, R. (2011) · Arthritis Care & Research · doi:10.1002/acr.20404 · Cited by 200
Baughman, R. P., Judson, M. A., Costabel, U., duBois, R. M., Drent, M., Kavuru, M., Lo, K. H., Andresen, C., Schlenker-Herceg, R., & Barnathan, E. S. (2005) · Chest · doi:10.1378/chest.128.2.1062 · Cited by 194
Lozeron, P., Denier, C., Lacroix, C., & Adams, D. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.11 · Cited by 190
Tumor necrosis factor α blockade with infliximab for refractory uveitis and scleritis
Murphy, C. C., Ayliffe, W. H., Booth, A., Makanjuola, D., Andrews, P. A., & Jayne, D. (2004) · Ophthalmology · doi:10.1016/s0161-6420(03)00721-8 · Cited by 188
Adalimumab in juvenile idiopathic arthritis-associated chronic anterior uveitis
Tynjala, P., Kotaniemi, K., Lindahl, P., Latva, K., Aalto, K., Honkanen, V., & Lahdenne, P. (2007) · Rheumatology · doi:10.1093/rheumatology/kem356 · Cited by 185
Kempen, J. H., Daniel, E., Dunn, J. P., Foster, C. S., Gangaputra, S., Hanish, A., Helzlsouer, K. J., Jabs, D. A., Kacmaz, R. O., Levy-Clarke, G. A., et al. (2009) · BMJ · doi:10.1136/bmj.b2480 · Cited by 185
Self-citationCytokines in Autoimmune Uveitis
Horai, R., & Caspi, R. R. (2011) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2011.0042 · Cited by 178
Experimental Autoimmune Uveoretinitis in the Rat and Mouse
Caspi, R. R. (2003) · Current Protocols in Immunology · doi:10.1002/0471142735.im1506s53 · Cited by 176
Aqueous humor interleukin-6 levels in uveitis.
Murray, P. I., Hoekzema, R., Haren, M. A. C. V., et al. (1990) · PubMed · Cited by 171
Etanercept and uveitis in patients with juvenile idiopathic arthritis
Schmeling, H., & Horneff, G. (2005) · Rheumatology · doi:10.1093/rheumatology/keh658 · Cited by 169
Anti-TNF- therapy for sight threatening uveitis
Lindstedt, E. W. (2005) · British Journal of Ophthalmology · doi:10.1136/bjo.2003.037192 · Cited by 168
Rossman, M. D., Newman, L. S., Baughman, R. P., Teirstein, A. S., Weinberger, S. E., Miller, W. T., & Sands, B. E. (2006) · PubMed · Cited by 166
El-Shabrawi, Y., & Hermann, J. (2002) · Ophthalmology · doi:10.1016/s0161-6420(02)01292-7 · Cited by 164
Retrospective Case Review of Pediatric Patients with Uveitis Treated with Infliximab
RAJARAMAN, R., KIMURA, Y., LI, S., HAINES, K., & CHU, D. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2005.09.037 · Cited by 164
Heiligenhaus, A., Michels, H., Schumacher, C., Kopp, I., Neudorf, U., Niehues, T., Baus, H., Becker, M. D., Bertram, B., Dannecker, G. E., et al. (2011) · Rheumatology International · doi:10.1007/s00296-011-2126-1 · Cited by 150
Dick, A. D., McMenamin, P. G., Körner, H., Scallon, B. J., Ghrayeb, J., Forrester, J. V., & Sedgwick, J. D. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260510 · Cited by 146
Etanercept for Refractory Ocular Sarcoidosis
Baughman, R. P., Lower, E. E., Bradley, D., Raymond, L. A., & Kaufman, A. H. (2005) · CHEST Journal · doi:10.1016/s0012-3692(15)50471-6 · Cited by 145
Tabbara, K. F., & Al-Hemidan, A. I. (2008) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2008.09.010 · Cited by 136
Kempen, J. H., Gangaputra, S. S., Daniel, E., Levy-Clarke, G. A., Nussenblatt, R. B., Rosenbaum, J. T., Suhler, E. B., Thorne, J. E., Foster, C. S., Jabs, D. A., et al. (2008) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2008.04.035 · Cited by 136
Self-citationADVERSE EVENTS AFTER INTRAVITREAL INFLIXIMAB (REMICADE)
GIGANTI, M., Beer, P. M., Lemanski, N., HARTMAN, C. L., Schartman, J., & Falk, N. S. (2010) · Retina · doi:10.1097/iae.0b013e3181bcef3b · Cited by 130
IL-10 has a protective role in experimental autoimmune uveoretinitis
Rizzo, L. V. (1998) · International Immunology · doi:10.1093/intimm/10.6.807 · Cited by 130
Infliximab for juvenile idiopathic arthritis‐associated uveitis
Richards, J. C., Tay‐Kearney, M., Murray, K. J., & Manners, P. (2005) · Clinical and Experimental Ophthalmology · doi:10.1111/j.1442-9071.2005.01062.x · Cited by 128
Zhou, H. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270004273321 · Cited by 125
Yamada, Y., Sugita, S., Tanaka, H., Kamoi, K., Kawaguchi, T., & Mochizuki, M. (2009) · British Journal of Ophthalmology · doi:10.1136/bjo.2009.158840 · Cited by 124
Markomichelakis, N. N., Delicha, E. M., Masselos, S., Fragiadaki, K., Kaklamanis, P. G., & Sfikakis, P. P. (2010) · Rheumatology · doi:10.1093/rheumatology/keq366 · Cited by 124
Ardoin, S. P., Kredich, D. W., Rabinovich, E., Schanberg, L. E., & Jaffe, G. J. (2007) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.08.018 · Cited by 112
Infliximab in chronic ocular inflammation
Baughman, R. P., Bradley, D., & Lower, E. E. (2005) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp43007 · Cited by 112
Identification of the lymphokines, interferon-gamma and interleukin-2, in inflammatory eye diseases.
Hooks, J. J., Chan, C., & Detrick, B. (1988) · PubMed · Cited by 110
Infliximab Treatment for Ocular and Extraocular Manifestations of Behçet's Disease
Accorinti, M., Pirraglia, M. P., Paroli, M. P., Priori, R., Conti, F., & Pivetti‐Pezzi, P. (2007) · Japanese Journal of Ophthalmology · doi:10.1007/s10384-006-0425-y · Cited by 110
Theis, V., & Rhodes, J. M. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03553.x · Cited by 108
Biological response modifier therapy for refractory childhood uveitis
Gallagher, M. J., Quinones, K., Cervantes-Castañeda, R. A., Yilmaz, T., & Foster, C. S. (2007) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.124081 · Cited by 106
Etanercept: therapeutic use in patients with rheumatoid arthritis
Garrison, L., & McDonnell, N. D. (1999) · Annals of the Rheumatic Diseases · doi:10.1136/ard.58.2008.i65 · Cited by 106
Long-term treatment of refractory posterior uveitis with anti-TNFα (infliximab)
Benitez-del-Castillo, J. M., Martínez-de-la-Casa, J. M., Pato-Cour, E., Méndez-Fernández, R., Lopez-Abad, C., Matilla, M. T., & Garcia-Sanchez, J. (2004) · Eye · doi:10.1038/sj.eye.6701689 · Cited by 103
Fouache, D., Goëb, V., Massy‐Guillemant, N., et al. (2009) · Lara D. Veeken · doi:10.1093/rheumatology/kep083 · Cited by 100
Simonini, G., Taddio, A., Cattalini, M., Caputo, R., de Libero, C., Parentin, F., Pagnini, I., Lepore, L., & Cimaz, R. (2013) · Pediatric Rheumatology · doi:10.1186/1546-0096-11-16 · Cited by 96
Autoimmunity in the immune privileged eye: pathogenic and regulatory T cells
Caspi, R. R. (2008) · Immunologic Research · doi:10.1007/s12026-008-8031-3 · Cited by 94
Saurenmann, R. K., Levin, A. V., Feldman, B. M., Laxer, R. M., Schneider, R., & Silverman, E. D. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.08.044 · Cited by 91
Robertson, M., Liversidge, J., Forrester, J. V., & Dick, A. D. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-1156 · Cited by 89
TNFα as Therapeutic Target: New Drugs, More Applications
Reimold, A. M. (2002) · Current Drug Targets - Inflammation & Allergy · doi:10.2174/1568010023344535 · Cited by 87
Beigel, F., Schnitzler, F., Paul Laubender, R., Pfennig, S., Weidinger, M., Göke, B., Seiderer, J., Ochsenkühn, T., & Brand, S. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21362 · Cited by 84
Caspi, R. R., Sun, B., Agarwal, R. K., Silver, P. B., Rizzo, L. V., Chan, C., Wiggert, B. O., & Wilder, R. L. (1997) · Eye · doi:10.1038/eye.1997.53 · Cited by 79
TUMOR NECROSIS FACTOR-α BLOCKADE IN THE TREATMENT OF RHEUMATOID ARTHRITIS
Keystone, E. C. (2001) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70211-8 · Cited by 75
ANTI-TUMOR NECROSIS FACTOR-α MONOCLONAL ANTIBODY THERAPY FOR RHEUMATOID ARTHRITIS
Kavanaugh, A. F. (1998) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70028-4 · Cited by 72
Induction of autoantibodies during prolonged treatment with infliximab.
Louis, M., Rauch, J., Armstrong, M., & Fitzcharles, M. (2003) · PubMed · Cited by 72
Farvardin, M., Afarid, M., & Shahrzad, S. (2012) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2011.0199 · Cited by 65
A Pilot Study on Ocular Safety of Intravitreal Infliximab in a Rabbit Model
Giansanti, F., Ramazzotti, M., Vannozzi, L., Rapizzi, E., Fiore, T., Iaccheri, B., Degl’Innocenti, D., Moncini, D., & Menchini, U. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0932 · Cited by 64
Loss of efficacy during long-term infliximab therapy for sight-threatening childhood uveitis
Simonini, G., Zannin, M. E., Caputo, R., Falcini, F., de Martino, M., Zulian, F., & Cimaz, R. (2008) · Rheumatology · doi:10.1093/rheumatology/ken298 · Cited by 64
Sarcoid-like granulomatous disease following etanercept treatment for RA.
Kudrin, A., Chilvers, E. R., Ginawi, A., Hazleman, B. L., Griffiths, M. H. G., Thiru, S., & Östör, A. J. K. (2007) · PubMed · Cited by 59
Novel, non-antigen-specific therapeutic approaches to autoimmune/inflammatory diseases
Illei, G. G., & Lipsky, P. E. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00167-9 · Cited by 54
Arias, L., Mitjana, J. M. C., Badia, M., Rubio, M., Català, J., & Goyta, O. P. (2010) · Retina · doi:10.1097/iae.0b013e3181e9f942 · Cited by 53
Developments in the scientific and clinical understanding of the spondyloarthritides
Sieper, J. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2562 · Cited by 49
Is there truly a risk of lymphoma from biologic therapies?
Dommasch, E. D., & Gelfand, J. M. (2009) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2009.01258.x · Cited by 49
Timing of recurrent uveitis in patients with Behcet's disease receiving infliximab treatment
Yamada, Y., Sugita, S., Tanaka, H., Kamoi, K., Takase, H., & Mochizuki, M. (2010) · British Journal of Ophthalmology · doi:10.1136/bjo.2009.168856 · Cited by 48
Infliximab Therapy for 2 Patients with Vogt-Koyanagi-Harada Syndrome
Wang, Y., & Gaudio, P. A. (2008) · Ocular Immunology and Inflammation · doi:10.1080/09273940802204527 · Cited by 46
Sen, E. S., Sharma, S., Hinchcliffe, A., Dick, A. D., & Ramanan, A. V. (2012) · Rheumatology · doi:10.1093/rheumatology/kes212 · Cited by 45
Petropoulos, I., Vaudaux, J. D., & Guex‐Crosier, Y. (2008) · Klinische Monatsblätter für Augenheilkunde · doi:10.1055/s-2008-1027361 · Cited by 42
Tuberculous uveitis after treatment with etanercept
Fonollosa, A., Segura, A., Giralt, J., & García‐Arumí, J. (2007) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-007-0549-x · Cited by 40
Autoimmune uveitis: The associated proinflammatory molecules and the search for immunoregulation
Commodaro, A. G., Bueno, V., Belfort, R., & Rizzo, L. V. (2010) · Autoimmunity Reviews · doi:10.1016/j.autrev.2010.10.002 · Cited by 38
Pulido, J. S., Pulido, J. S., Michet, C. J., & Vile, R. G. (2010) · Retina · doi:10.1097/iae.0b013e3181cde727 · Cited by 36
Anti-TNFalpha blockers, autoantibodies and autoimmune diseases
Caramaschi, P., Bambara, L. M., Pieropan, S., Tinazzi, I., Volpe, A., & Biasi, D. (2009) · Joint Bone Spine · doi:10.1016/j.jbspin.2008.12.008 · Cited by 36
Wu, L., Arévalo, J. F., Hernández-Bogantes, E., Regatieri, C. V., Roca, J. A., & Farah, M. E. (2012) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2012.0203 · Cited by 33
Cheng, Y.-J., Yang, B.-C., Hsieh, W.-C., Huang, B., & Liu, M. (2002) · Toxicology · doi:10.1016/s0300-483x(02)00225-1 · Cited by 32
Greten, T. F., Manns, M. P., Reinisch, I., & Kaatsch, P. (2005) · Gut · doi:10.1136/gut.2004.059352 · Cited by 28
Auditing the implementation of SIGN clinical guidelines
Keaney, M., & Lorimer, A. R. (1999) · International Journal of Health Care Quality Assurance · doi:10.1108/09526869910297331 · Cited by 27
Uveitis associated with sarcoidosis exacerbated by etanercept therapy
Suzuki, J., & Gotô, H. (2009) · Japanese Journal of Ophthalmology · doi:10.1007/s10384-009-0691-6 · Cited by 26
Effects of Systemic and Intravitreal TNF-α Inhibition in Experimental Autoimmune Uveoretinitis
Busch, M., Bauer, D., Hennig, M., Wasmuth, S., Thanos, S., & Heiligenhaus, A. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-10138 · Cited by 24
Hoffman, V., Norman, H. S., Alexander, K. A., Napalkov, P., & Enger, C. L. (2012) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2012.05.004 · Cited by 18
Beigel, F., Schnitzler, F., Göke, B., Ochsenkühn, T., & Brand, S. (2010) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0030-1263682 · Cited by 15
Biologics in inflammatory disease: infliximab associated risk of lymphoma development
Bucher, C., Degen, L., Dirnhofer, S., Pless, M., Herrmann, R., Schraml, P., & Went, P. (2005) · HighWire Press Open Archive · Cited by 9
Cited by
Adalimumab in Patients with Active Noninfectious Uveitis
Jaffe, G. J., Dick, A. D., Brézin, A. P., Nguyen, Q. D., Thorne, J. E., Kestelyn, P., Barisani-Asenbauer, T., Franco, P., Heiligenhaus, A., Scales, D., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1509852 · Cited by 674
Nguyen, Q. D., Merrill, P. T., Jaffe, G. J., Dick, A. D., Kurup, S. K., Sheppard, J., Schlaen, A., Pavesio, C., Cimino, L., Van Calster, J., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31339-3 · Cited by 536
Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis
Ramanan, A. V., Dick, A. D., Jones, A. P., McKay, A., Williamson, P. R., Compeyrot-Lacassagne, S., Hardwick, B., Hickey, H., Hughes, D., Woo, P., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1614160 · Cited by 437
Angeles‐Han, S. T., Ringold, S., Beukelman, T., Lovell, D., Cuello, C. A., Becker, M. L., Colbert, R. A., Feldman, B. M., Holland, G. N., Ferguson, P. J., et al. (2019) · Arthritis Care & Research · doi:10.1002/acr.23871 · Cited by 316
Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveitis
Dick, A. D., Rosenbaum, J. T., Al-Dhibi, H. A., Belfort, R., Brézin, A. P., Chee, S. P., Davis, J. L., Ramanan, A. V., Sonoda, K.-H., Carreño, E., et al. (2018) · Ophthalmology · doi:10.1016/j.ophtha.2017.11.017 · Cited by 285
Self-citation
Metadata
- Authors
- Levy-Clarke, G., Jabs, D. A., Read, R. W., Rosenbaum, J. T., Vitale, A., & Van Gelder, R. N.
- Venue
- Ophthalmology
- Publisher
- Elsevier BV
- Published
- 2014-03
- Volume
- 121
- Issue
- 3
- Pages
- 785-796.e3
- ISSN
- 0161-6420 (ISSN-L)
- OpenAlex
- W2006142366
- Cited by
- 483
- References
- 114
- FWCI
- 31.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.